| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/15/2005 | US20050202395 Using photoreactive layer as screen to remove pathogens from biological fluids |
| 09/15/2005 | US20050202048 Chlamydia antigens and vaccine uses of the protein |
| 09/15/2005 | US20050202036 Alternate reading frame polypeptides drived from hepatitis C and methods of their use |
| 09/15/2005 | US20050202030 Method of evaluating the therapeutic potential of a vaccine for mucosal administration |
| 09/15/2005 | US20050202025 Antibodies to the FbsA protein of streptococcus agalactiae and their use in treating or preventing infections |
| 09/15/2005 | US20050202020 Diagnosing and treating cancer |
| 09/15/2005 | US20050202019 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 09/15/2005 | US20050202017 Assay; contacting a test compound with a HB-954 polypeptide; determining whether the test compound binds to the G protein-coupled receptor |
| 09/15/2005 | US20050202016 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 09/15/2005 | US20050202015 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue |
| 09/15/2005 | US20050202013 Novel Th2-specific molecules and uses thereof |
| 09/15/2005 | US20050202011 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith |
| 09/15/2005 | US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 09/15/2005 | US20050202007 Determining a P-selectin activity in a biological sample of the subject,increased P-selectin activity in the sample indicates a procoagulant state in the subject |
| 09/15/2005 | US20050202002 Reagent; polyclonal or monoclonal antibody against the protease or its proenzyme which activates blood clotting factor VII, is inhibited by the presence of aprotinin, is increased in its activity by calcium ions, heparin, or heparin related substance |
| 09/15/2005 | US20050201992 Culture with human dendritic cells wherein the hybrid cells were generated by fusing tumor cells dissociated from a tumor by mechanical dissociation with a highly enriched population of human B-cells; avoiding the problems of immune suppression, autoimmune reactions, and self-recognition; kits; antitumor |
| 09/15/2005 | US20050201979 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 09/15/2005 | US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 09/15/2005 | US20050201975 Modifying chemokine G-protein mediated signalling and/or signal transduction by administering a modulator of the Notch signalling pathway; using a fusion protein of a segment of a Notch ligand extracellular domain and an immunoglobulin Fc segment or a polynucleotide encoding it; antiinflammatory agents |
| 09/15/2005 | US20050201973 Therapeutic supramolecules |
| 09/15/2005 | US20050201938 Method for selectively inhibiting ghrelin action |
| 09/15/2005 | US20050201937 Creation of a gradient of isotope enrichment; ability to measure a multiplicity of isotope enrichments simultaneously |
| 09/15/2005 | US20050201931 LAT1 transporters expressed in blood brain barrier cells |
| 09/15/2005 | US20050201897 Tape adapted to collect body fluid; supplyportion for storing an uncontaminated section;exposure portion positioned between; medical equipment; blood glucose |
| 09/15/2005 | US20050201892 Analytical instrument |
| 09/15/2005 | US20050201197 System and method for mixing water and non-aqueous materials using measured water concentration to control addition of ingredients |
| 09/15/2005 | US20050200354 Method and apparatus for determing the thickness of a chromium depleted zone of a surface region of a steel member |
| 09/15/2005 | US20050199917 Sensitivity enhanced biomolecule field effect transistor |
| 09/15/2005 | US20050199804 Electron transfer dissociation for biopolymer sequence analysis |
| 09/15/2005 | US20050199496 Apparatus and process for sensing fluoro species in semiconductor processing systems |
| 09/15/2005 | US20050199111 Automated product profiling apparatus and product slicing system using same |
| 09/15/2005 | US20050199078 Method and apparatus for determination of the depth of depressions which are formed in a mount substrate |
| 09/15/2005 | US20050199037 Pump for supplying a gas to a sensor and methods therefor |
| 09/15/2005 | DE19741809B4 Verfahren zur Gesamtschwefelbestimmung Method for determination of total sulfur |
| 09/15/2005 | DE19545181B4 Pulverzerstäuber Powder sprayer |
| 09/15/2005 | DE102005007187A1 Predicting quality of brake fluid in motor vehicle braking system, by using mathematical calculation based on measurements from braking medium sensor |
| 09/15/2005 | DE102004056742A1 Verfahren und Vorrichtung zur berührungslosen Detektion von flächigen Objekten Method and device for the contactless detection of sheet-like objects |
| 09/15/2005 | DE102004022763B3 Device for determining the oxygen activity in metal or slag melts, useful for measuring the content of silicon and carbon, includes solid electrolyte coated with layer of zirconium silicate and a fluoride |
| 09/15/2005 | DE102004011503A1 Identifying and quantifying tumor-associated peptides by chemically identically modifying peptides to generate different physical characteristics, useful for treating tumorous and/or adenomatous diseases |
| 09/15/2005 | DE102004010650A1 Two-component reagent for determining water content of substance, especially oil, uses white spirit and component containing petroleum jelly, liquid paraffin and alkali(ne earth) hydride, stored separately and mixed only after transport |
| 09/15/2005 | DE102004010217A1 Anordnung und Verfahren zur spektroskopischen Bestimmung der Bestandteile und Konzentrationen pumpfähiger organischer Verbindungen Apparatus and method for spectroscopic determination of constituents and concentrations of pumpable organic compounds |
| 09/15/2005 | DE102004009704A1 New conjugates useful for labeling nucleic acids comprise a label coupled to nucleotide or nucleoside molecules through polymer linkers |
| 09/15/2005 | DE102004009012A1 Testelement mit einer Kapillare zum Transport einer flüssigen Probe Test element with a capillary for transporting a liquid sample |
| 09/15/2005 | DE102004007462A1 Antikörper sowie Verfahren zur Diagnose und Behandlung von Schizophrenie Antibodies, and methods for diagnosis and treatment of schizophrenia |
| 09/15/2005 | DE10161051B4 Diagnose der Malaria Diagnosis of malaria |
| 09/15/2005 | DE10000738B4 Festkörpererkennung mittels elektronischer Nase Solid-state recognition using electronic nose |
| 09/15/2005 | CA2773645A1 Body fluid sampling device |
| 09/15/2005 | CA2600108A1 Granulocyte subtype-selective receptors and ion channels and uses thereof |
| 09/15/2005 | CA2559091A1 Detection of preterm labour |
| 09/15/2005 | CA2558721A1 Screening method for emulators of neural activity and digestive system using gpr35 |
| 09/15/2005 | CA2558670A1 Methods of evaluating efficacy of an immune response by assessing alpha-1 integrin expression |
| 09/15/2005 | CA2558664A1 Functional method for generating or screening for ligands which modulate steroid hormone receptors |
| 09/15/2005 | CA2558596A1 Anti fk778 antibodies and high sensitive immunoassay methods |
| 09/15/2005 | CA2558399A1 Partially loaded antibodies and methods of their conjugation |
| 09/15/2005 | CA2558271A1 Immobilized biomolecule and method of detecting substance capable of interacting with biomolecule |
| 09/15/2005 | CA2558022A1 Triboacoustic sensor |
| 09/15/2005 | CA2557819A1 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 09/15/2005 | CA2557761A1 Method of detecting carcinogenesis caused by hepatitis b virus |
| 09/15/2005 | CA2557568A1 Pharmacodynamic assays using flow cytometry |
| 09/15/2005 | CA2557563A1 Particle on membrane assay system |
| 09/15/2005 | CA2557347A1 Systems and methods for disease diagnosis |
| 09/15/2005 | CA2555912A1 Functional materials and novel methods for the fabrication of microfluidic devices |
| 09/15/2005 | CA2555656A1 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis |
| 09/15/2005 | CA2552425A1 Method of assessing rheumatoid arthritis by measuring rheumatoid factor and interleukin-6 |
| 09/15/2005 | CA2552420A1 Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a |
| 09/15/2005 | CA2537796A1 Personal diagnostic devices and related methods |
| 09/15/2005 | CA2500926A1 Tumor/b-cell hybrid cells and uses thereof |
| 09/15/2005 | CA2500025A1 Method and apparatus for detecting endometriosis |
| 09/14/2005 | EP1574860A1 Method of analyzing c-terminal amino acid sequence of peptide |
| 09/14/2005 | EP1574859A1 Method for characterizing man-made surfaces |
| 09/14/2005 | EP1574858A1 Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid |
| 09/14/2005 | EP1574857A1 Assay system for specific inhibitors of protein kinase C-related kinases |
| 09/14/2005 | EP1574856A1 Method of screening cell growth inhibitor and cell growth inhibitor |
| 09/14/2005 | EP1574855A1 Portable device for analysis |
| 09/14/2005 | EP1574854A1 Immobilizing chemical or biological sensing molecules on semi-conducting nanowires |
| 09/14/2005 | EP1574853A1 Monitoring fluid condition by electro-impedance measurement |
| 09/14/2005 | EP1574852A1 Method of measuring biodegradation rate of unnatural organic compound |
| 09/14/2005 | EP1574839A1 Sample analyzer and computer program product |
| 09/14/2005 | EP1574838A1 Device for collecting information on biological particle |
| 09/14/2005 | EP1574837A1 Method and apparatus for sequencing polymers through tunneling conductance variation detection |
| 09/14/2005 | EP1574836A1 Method and test kit for testing of indoor air for harmful substances |
| 09/14/2005 | EP1574607A2 Quality control method for fiber bundle in spinning machine |
| 09/14/2005 | EP1574583A1 Methods for isolation of bacteria from biological samples |
| 09/14/2005 | EP1574579A2 Outer surface proteins, their genes, and their use |
| 09/14/2005 | EP1574577A2 Growth differentiation factor-11 |
| 09/14/2005 | EP1574575A1 GLUCOSE AND/OR FRUCTOSE TRANSPORTER NaGLT1 AND ITS GENE |
| 09/14/2005 | EP1574569A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same |
| 09/14/2005 | EP1574519A1 Transcription control factor ZHX3 |
| 09/14/2005 | EP1574517A1 HCV E1 comprising specific disulfide bridges |
| 09/14/2005 | EP1573776A2 Method for producing a sample carrier for maldi-mass spectrometry |
| 09/14/2005 | EP1573639A2 Method for enhanced accuracy in predicting the elution times of peptides using liquid separations or chromatography |
| 09/14/2005 | EP1573637A2 Amino acid sequence pattern matching |
| 09/14/2005 | EP1573636A2 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 09/14/2005 | EP1573634A2 System method, and computer software product for controlling biological microarray scanner |
| 09/14/2005 | EP1573443A2 Stellar icon for data representation and system and method forming the stellar icon |
| 09/14/2005 | EP1573416A2 Medical system, method and apparatus employing mems |
| 09/14/2005 | EP1573339A2 Detection or determination of variants of factor xiia |
| 09/14/2005 | EP1573337A1 Prp detection method using an ancillary macrocyclic ligand |
| 09/14/2005 | EP1573336A1 Prp detection method using an aminoglycoside antibiotic |
| 09/14/2005 | EP1573335A2 Cvd assay |